advertisement
Lämmer R 18
Showing records 1 to 18 | Display all abstracts from Lämmer R96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Hohberger B
Frontiers in medicine 2021; 8: 754667
95970 Blue-Yellow VEP with Projector-Stimulation in Glaucoma
Dussan Molinos L
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 1171-1181
96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Hohberger B
Frontiers in neuroscience 2021; 15: 676579
95970 Blue-Yellow VEP with Projector-Stimulation in Glaucoma
Huchzermeyer C
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 1171-1181
96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Harrer T
Frontiers in medicine 2021; 8: 754667
96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Schlötzer-Schrehard U
Frontiers in neuroscience 2021; 15: 676579
96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Mardin C
Frontiers in medicine 2021; 8: 754667
96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Mardin C
Frontiers in neuroscience 2021; 15: 676579
95970 Blue-Yellow VEP with Projector-Stimulation in Glaucoma
Lämmer R; Kremers J
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 1171-1181
96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Lämmer R
Frontiers in neuroscience 2021; 15: 676579
96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Kruse F; Hoffmanns J
Frontiers in medicine 2021; 8: 754667
96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Munoz L
Frontiers in neuroscience 2021; 15: 676579
95970 Blue-Yellow VEP with Projector-Stimulation in Glaucoma
Horn FK
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 1171-1181
96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Rogge L
Frontiers in medicine 2021; 8: 754667
96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Kunze R
Frontiers in neuroscience 2021; 15: 676579
96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Heltmann F
Frontiers in medicine 2021; 8: 754667
96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Herrmann M; Wallukat G
Frontiers in neuroscience 2021; 15: 676579
96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Moritz M; Szewczykowski C; Schottenhamml J; Kräter M; Bergua A; Zenkel M; Gießl A; Schlötzer-Schrehardt U; Lämmer R; Herrmann M; Haberland A; Göttel P; Müller J; Wallukat G
Frontiers in medicine 2021; 8: 754667